Risk stratification in chronic heart failure

European Heart Journal

Volumn 19, Issue 5, 1998, Pages 696-710

  Cowburn, P J ^a   Cleland, John G F ^a   Coats, A J S ^b   Komajda, M ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Heart failure; Mortality; Prognosis; Risk

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYTOKINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; MAGNESIUM; NORADRENALIN; SODIUM; UREA; WARFARIN;

AGE; ARTERIAL PRESSURE; ARTICLE; BODY WEIGHT; CAUCASIAN; CLINICAL EXAMINATION; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAGNESIUM BLOOD LEVEL; MEDICAL LITERATURE; MORTALITY; NEGRO; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PULSE RATE; RACE DIFFERENCE; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SUDDEN DEATH; SURVIVAL RATE; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; UREA BLOOD LEVEL;

ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 0032080509     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0820     Document Type: Article

References (211)

1. [1] Cohn JN. Prognostic factors in heart failure: poverty amidst a wealth of variables. J Am Coll Cardiol 1989; 14: 571-2.
2. [2] Ball SG, Hall AS, Mackintosh AF et al. Effect of ramipril and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8.
3. [3] Cleland JGF, Erhardt L, Murray G, Hall AS, Ball SG. Effect of ramipril and morbidity and mode of death among on survivors of acute myocardial infarction with clinical evidence of heart failure. Eur Heart J 1997; 18: 41-51.
4. [4] Ho KKL, Anderson KM, WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in the Framingham heart study subjects. Circulation 1993; 88: 107-15.
5. [5] Garg R, Yusuf S. Epidemiology of congestive heart failure. In: Barnett, DB, Pouler, H, Francis, GS, eds. Congestive Cardiac Failure - Pathophysiology and Treatment. Marcel Dekker, 1993: 9-25.
6. [6] Bourassa MG, Gurne O, Bangdiwala SL et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 12: 14A-19A.
7. [7] Adams KF, Dunlap SH, Sueta CA et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28: 1781-8.
8. [8] Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
9. [9] Mendes LA, Davidoff R, Cupples LA, Ryan TJ, Jacobs AK. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J 1997; 134: 207-12.
10. [10] Ghali JK, Weiner DH, Greenberg B, Adams, Benedict C, Quinones M, for the SOLVD registry investigators. Does gender have an impact on Survival of patients with heart failure? Findings from the SOLVD Registry (Abstr). J Am Coll Cardiol 1997; 29: 246A.
11. [11] Bart BA, Shaw LK, McCants CB et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997; 30: 1002-8.
12. [12] Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5.
13. [13] Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Arch Intern Med 1993; 87: 111-7.
14. [14] Teo K, Montague T, Ackman M et al. Mortality risk and patterns of practise in 4606 acute care patients with congestive heart failure - the relative importance of age, sex, and medical therapy. Arch Intern Med 1996; 156: 1669-73.
15. [15] Myers J, Gullestad L, Vagelos R et al. Clinical, hemodynamic, and cardiopulmonary exercise test predictors of outcome in patients referred for heart failure evaluation (Abstr). J Am Coll Cardiol 1997; 29: 527A.
16. [16] Clinical Quality Improvement Network Investigators, CQINSG. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. Arch Intern Med 1996; 156: 1669-73.
17. [17] Fuster V, Gersch BJ, Guiliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-31.
18. [18] Hughes CV, Wong M, Johnson G, Cohn JN. Influence of age on mechanisms and prognosis of heart failure. Circulation 1993; 87: VI111-17.
19. [19] Taffet G, Teasdale TA, Bleyer AJ et al. Survival of elderly men with congestive heart failure. Age Ageing 1992; 21: 49-55.
20. [20] Bedford PD, Caird FL. Congestive heart failure in the elderly. Q J Med 1956; 25: 407-11.
21. [21] Rich MW, Vinson JM, Sperry JC et al. Prevention of readmission in elderly patients with congestive heart failure: Results of a prospective, randomized pilot study. J Gen Intern Med 1993; 8: 585-90.
22. [22] Pernenkil R, Vinson JM, Shah AS, Beckham V, Wittenberg C, Rich MW. Course and prognosis in patients >70 yrs of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997; 79: 216-9.
23. [23] Cleland JGF. Clinical trials in heart failure. In: Julian DG, Pitt B, eds. Clinical Trials in Cardiology. London: Saunders, 1997: 309-54.
24. [24] Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990; 65: 903-8.
25. [25] Gradman A, Deedwania P, Cody R et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989; 14: 546-70.
26. [26] Madsen BK, Hansen JF, Stokholm KH et al Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994; 15: 303-10.
27. [27] van den Broek SA, Van Veldhuisen DJ, De Graeff PA, Landsman MLJ, Hillege H, Lie KI. Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischaemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70: 359-63.
28. [28] CIBIS Investigations and Committees. A randomized trial of B-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765-73.
29. [29] Gianuzzi P, Temporelli PL, Bosimini E et al. Independent and incremental prognostic value of doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 28: 383-90.
30. [30] O'Connor CM, Anderson SA, Meese RB et al. Clinical determinants of outcome in advanced heart failure: Insights from the PRAISE trial (Abstr). J Am Coll Cardiol 1997; 129: 246A.
31. [31] Pozzoli M, Traversi E, Cioffi G, Stenner R, Sanarico M, Tavazzi L. Loading manipulations improve the prognostic value of doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 1996; 95: 1222-30.
32. [32] Campana C, Gavazzi A, Berzuini C et al. Predictors of prognosis in patients awaiting heart transplantation. Jnl Heart Lung Transpl 1993; 12: 756-65.
33. [33] Johnson G, Carson P, Francis GS, Cohn JN. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril: Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). Circulation 1993; 87: V132-9.
34. [34] Walsh JT, Charlesworth A, Andrews R, Hawkins M, Cowley AJ. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Cardiol 1997; 79: 1364-9.
35. [35] Komajda M, Jais JP, Reeves B et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 1990; 11: 824-31.
36. [36] Rickenbacher PR, Trindade PT, Haywood GA et al. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristic and survival. J Am Coll Cardiol 1996; 27: 1192-7.
37. [37] Warner-Stevenson L, Fowler MB, Schroeder JS, Stevenson WG, Dracup KA, Fond V. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Med 1987; 83: 871-6.
38. [38] Steimle AE, Stevenson LW, Fonarow GA, Hamilton MA, Moriguchi JD. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 1994; 23: 553-9.
39. [39] Garg R, Yusuf S. Overview of randomized trails of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J Am Med Assoc 1995; 273: 1450-6.
40. [40] Cleland JGF, Bristow M, Erdmann E, Remme WJ, Swedberg K, Waggstein F. Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J 1996; 17: 1629-39.
41. [41] Middlekauf HR, Stevenson WG, Warner-Stevenson L, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993; 21: 110-6.
42. [42] Fruhwald FM, Eber B, Schumacher M et al. Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. Cardiology 1996; 87: 177-80.
43. [43] di Carli MF, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-33.
44. [44] Yusuf S, Pepine CJ, Garces C et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173-8.
45. [45] Franciosa JA, Wilen M, Ziesche S, Cohen JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831-6.
46. [46] Kelly TL, Cremo R, Nielson C, Shabeiti R. Prediction of outcome in late stage cardiomyopathy. Am Heart J 1990; 119: 1111-21.
47. [47] Cohn JN, Archibald DG, Ziesche S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314: 1547-52.
48. [48] Prazak P, Pfisterer M, Osswald S et al. Differences of disease progression in congestive heart failure due to alcoholic as compared to ideopathic dilated cardiomyopathy. Eur Heart J 1996; 17: 251-7.
49. [49] Aaronson KD, Schwartz JS, Chen T, Wong K, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-7.
50. [50] Nul DR, Grancelli HO, Varini SD et al. No ethiologic differences in survival benefits from amiodarone in severe congestive heart failure (Abstr). J Am Coll Cardiol 1997; 29: 247A.
51. [51] Yusuf S. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
52. [52] Shindler DM, Kostis JB, Yusuf S et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry. Am J Cardiol 1996; 77: 1017-20.
53. [53] Guillo P, Mansourati J, Maheeu B et al. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 1997; 79: 1276-8.
54. [54] Csanady M, Hogye M, Kallai A et al. Familial dilated cardiomyopathy: a worse prognosis compared with sporadic forms. Br Heart J 1995; 74: 171-3.
55. [55] Anker SD, Ponikowski P, Varney S et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-3.
56. [56] Nul DR, Doval HC, Grancelli HO et al. on behalf of the GESICA-GEMA investigators. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 1997; 29: 1199-205.
57. [57] Middlekauf HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991; 84: 40-8.
58. [58] Stevenson WG, Middlekauf HR, Stevenson LW et al. Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment of advanced heart failure. Am Heart J 1992; 124: 123-30.
59. [59] Hofmann T, Meinertz T, Kasper W et al. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 1988; 116: 1455-63.
60. [60] Romeo F, Pelliccia F, Cianfrocca C et al. Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 138-40.
61. [61] Unverferth DV, Magorien RD, Moeschberger ML et al. Factors influencing the one year mortality of dilated cardiomyopathy. Am J Cardiol 1984; 54: 147-52.
62. [62] Rockman HA, Juneau C, Chatterjee K, Rouleau J. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989; 64: 1344-8.
63. [63] Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: The V-HeFT studies. Circulation 1993; 87: VI102-VI110.
64. [64] Stevenson WG, Stevenson LW, Middlekauff HR et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996; 28: 1458-63.
65. [65] Cleland JGF, Dargie HJ, Ford I. Mortality in heart failure: Clinical variables of prognostic value. Br Heart J 1987; 58: 572-82.
66. [66] Anguita M, Arizon JM, Bueno G et al. Clinical and haemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 1993; 72: 413-7.
67. [67] Schwarz F, Mall G, Zebe H et al. Determinants of survival in patients with congestive cardiomyopathy: quantative morphologic findings and left ventricular hemodynamics. Circulation 1984; 70: 923-8.
68. [68] Glover DR, Littler WA. Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure. Br Heart J 1987; 57: 125-32.
69. [69] Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-8.
70. [70] Cleland JGF, Erdmann E, Ferrari R et al. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
71. [71] Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics heart failure. J Am Med Assoc 1989; 261: 884-8.
72. [72] Batin PD, Wickens M, McEntegart D et al. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995; 16: 1613-8.
73. [73] Francis GS, Benedict C, Johnstone DE et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990; 82: 1724-9.
74. [74] The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
75. [75] Cleland JGF, Bulpitt CJ, Falk RH et al. Is aspirin safe for patients with heart failure? Br Heart J 1995; 74: 215-9.
76. [76] Katz SD, Marantz PR, Biascucci L, Jondeau G, Lee K, Brennan C, LeJemtel TH. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J 1993; 126: 141-6.
77. [77] Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Effect of antiplatelet agents on survival in patients with left ventricular systolic dysfunction (Abstr). Circulation 1995; 92 (Suppl I): I-665-I-666.
78. [78] Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN. Incidence of thromboembolic events in congestive heart failure. Circulation 1993; 87: VI94-VI101.
79. [79] Cleland JGF. Anticoagulants and antiplatelet agents. In: Poole-Wilson P, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure. London: Churchill Livingstone, 1997: 759-3.
80. [80] Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Effect of warfarin anti-coagulation on survival in patients with left ventricular systolic dysfunction (Abstr). J Am Coll Cardiol 1996; 27 (Suppl A): 142.
81. [81] Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
82. [82] Doval HC, Nul DR, Grancelli HI, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-8.
83. [83] Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-67.
84. [84] Parameshwar J, Keegan J, Sparrow J. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123: 421-6.
85. [85] Nolan J, Batin PD, Andrews R et al. Preliminary results of the UK heart study: Heart rate variability independently predicts risk in ambulant chronic heart failure (Abstr). Heart 1997; 77: 29.
86. [86] Dargie HJ, Cleland JGF, Leckie BJ et al. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 1987; 75: IV-98-IV-107.
87. [87] Gottlieb SS, Baruch L, Kukin ML et al. Prognostic importance of the serum magnesium concentration in patients with CHF. J Am Coll Cardiol 1990; 16: 827-31.
88. [88] Haber HL, Leavy JA, Kessler PD et al. The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med 1991; 324: 353-8.
89. [89] Soifer S, Nul DR, Grancelli HO et al. Different predictors in sudden or progressive heart failure death in severe heart failure (Abstr). J Am Coll Cardiol 1997; 29: 247A.
90. [90] Madsen BK, Keller N, Christiansen E, Christensen NJ. Prognostic value of plasma catecholomines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity. Cardiac Failure 1995; 1: 207-16.
91. [91] Cohn J, Levine TB, Olivari MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-23.
92. [92] Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82: 1730-6.
93. [93] Cohn JN, Johnson GR, Shabetai R et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87: VI5-VI16.
94. [94] Benedict CR, Shelton B, Johnstone DE et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94: 690-7.
95. [95] Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989; 13: 1534-9.
96. [96] Dickstein K, Larsen AL, Bonarjee V et al. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol 1995; 76: 679-83.
97. [97] Hall C, Kjekshus J, Eneroth P, Snapinn S. The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure. Clin Cardiol 1994; 17: 191-5.
98. [98] Tsutamoto T, Maeda K, Hisanaga T et al. Plasma brain natriuretic peptide concentration as a prognostic predictor in patients with symptomatic left ventricular dysfunction (Abstr). Circulation 1996; 94: 1-255.
99. [99] Arakawa N, Nakamura M, Hidehiko A, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1656-61.
100. [100] Omland T, Aakvaag A, Bonarjee V et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996; 93: 1963-9.
101. [101] Cleland JGF, Cowburn PJ, Morgan K. Neuroendocrine activation after myocardial infarction: causes and consequences. Heart 1996; 76 (Suppl 3): 53-59.
102. [102] Hall C, Rouleau JL, Moye L et al. N-terminal proatrial natriuretic factor: An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994; 89: 1934-42.
103. [103] Pousset F, Isnard R, Lechat P et al. Plasma endothelin-1 is a strong prognostic marker in chronic heart failure. Eur Heart J 1997; 18: 254-8.
104. [104] Cody RJ, Naas GJ, Binkley PF, Capers O, Kelly R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992; 85: 504-9.
105. [105] Pacher R, Stanek B, Hulsmann M et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive haemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27: 633-41.
106. [106] Stanek B, Frey B, Julsmann M et al. Validation of big endothelin plasma levels compared with established neurohormonal markers in patients with severe chronic heart failure. Transplant Proc 1997; 29: 595-6.
107. [107] Hulsman M, Stanek B, Frey B, Putz D, Kos T, Sturm B, Pacher R. Value of big endothelin plasma levels at rest compared to peak oxygen consumption during exercise to predict mortality and need of urgent cardiac transplantation in patients with heart failure (Abstr). Heart Failure '97 1997; Cologne: 87.
108. [108] Tsutamoto T, Hisanaga T, Fukai D et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995; 76: 803-8.
109. [109] Levine B, Kalman J, Mayer L et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
110. [110] Ferrari R, Bachetti T, Confortini R et al. Tumor necrosis factor soluble receptors in patients with various degrees of heart failure. Circulation 1995; 92: 1479-86.
111. [111] McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-6.
112. [112] Schoeller R, Andresen D, Buttner et al. First-or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 71: 720-6.
113. [113] Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996; 53: 163-70.
114. [114] Olshausen KV, Steinen U, Math D et al. Long term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1988; 61: 146-51.
115. [115] Brembilla-Perrot B, Terrier de la Chasse A, Jacquemin L, Beurrier D, Houplon P. The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. Am J Cardiol 1997; 79: 154-9.
116. [116] Silverman ME, Pressel MD, Brackett JC et al. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 1995; 75: 460-4.
117. [117] Saxon LA, Stevenson WG, Middlekauff HR, Stevenson LW. Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J 1993; 125: 1306-10.
118. [118] Saxon LA, Stevenson WG, Middlekauff HR et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 72: 62-5.
119. [119] Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993; 87: 1083-92.
120. [120] Turrito G, Ahuja RK, Caref EB, El-Sherif N. Risk stratification for arrhythmic events in patients with nonischaemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal averaged electrocardiogram. J Am Coll Cardiol 1994; 24: 1523-8.
121. [121] Poll DS, Marchlinski FE, Falcone RA, Josephson ME, Simson MB. Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias. Circulation 1985; 72: 1308-13.
122. [122] Gonska BD, Bethge KP, Figulla HR, Kreuzer H. Occurrence and clinical significance of endocardial late potentials and fractionations in idiopathic dilated cardiomyopathy. Br Heart J 1988; 59: 39-46.
123. [123] Ohnishi Y, Inoue T, Fukuzaki H. Value of the signal-averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy. Jpn Circ 1990; 54: 127-36.
124. [124] Keeling PJ, Kulakowski P, Yi G, Slade AKB, Bent SE, McKenna WJ. Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias. Am J Cardiol 1993; 72: 78-84.
125. [125] Denereaz D, Zimmerman M, Adamec R. Significance of ventricular late potentials in non-ischaemic dilated cardiomyopathy. Eur Heart J 1992; 13: 895-901.
126. [126] Yi G, Keeling PJ, Goldman JH, Jian H, Poloniecki J, McKenna WJ. Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1995; 75: 494-7.
127. [127] Middlekauf HR, Stevenson WG, Woo MA et al. Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol 1990; 66: 1113-7.
128. [128] Galinier M, Albenque JP, Afchar et al. Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J 1996; 17: 264-71.
129. [129] Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327-9.
130. [130] Brooksby P, Lindsay SJ, Batin PD et al. QT dispersion is predictive of mortality in patients with chronic stable heart failure (Abstr). Circulation 1996; 94: 1-450.
131. [131] Zareba W, Moss AJ, Cessie SI. Dispersion of ventricular repolarisation and arrhythmic death in coronary artery disease. Am J Cardiol 1994; 74: 550-3.
132. [132] Pinsky DJ, Sciacca RR, Steinberg JS. Dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 1997; 29: 1576-84.
133. [133] Fei L, Goldman JH, Prasad K et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996; 17: 258-63.
134. [134] Grimm W, Steder U, Menz V et al. QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 78: 458-61.
135. [135] Fu GS, Meissner A, Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J 1997; 18: 281-9.
136. [136] Reese DB, Silverman ME, Gold MR, Gottlieb SS. Prognostic importance of the length of ventricular tachycardia in patients with nonischaemic congestive heart failure. Am Heart J 1995; 130: 489-93.
137. [137] De Maria R, Gavazzi A, Caroli A et al. Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 1992; 69: 1451-7.
138. [138] Wilson JR, Schwartz JS, Sutton MS et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983; 2: 403-10.
139. [139] Massie BM, Francis GS, Tandon PK et al. Asymptomatic ventricular arrhythmias do not identify patients with severe heart failure at risk of sudden death (Abstr). J Am Coll Cardiol 1993; 21: 459a.
140. [140] Massie BM, Podrid PJ, Hendrix GH et al. Does asymptomatic worsening of arrhythmia predict sudden death in heart failure? Evidence for clinically significant proarrhythmia during milrinone therapy (Abstr). J Am Coll Cardiol 1992; 19: 78A.
141. [141] Gomes JA, Mehta D, Ip J, Winters SL et al. Predictors of long-term survival in patients with malignant ventricular arrhythmias. Am J Cardiol 1997; 79: 1054-60.
142. [142] Brouwer J, Van Veldhuisen D, Man in t Veld AJ et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol 1996; 28: 1183-9.
143. [143] Gibelin P, Dadoun-Dybal. Heart rate variability in chronic heart failure: prognostic value (Abstr). Eur Heart J 1996; 17: 28.
144. [144] Madsen BK, Rasmussen V, Hansen JF. Predictors of sudden death and death from pump failure in heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 1997; 58: 151-62.
145. [145] Nolan JP, Batin PD, Lindsey SJ et al. Reduced heart rate variability and mortality in chronic heart failure (Abstr). Circulation 1996; 94: 1-498.
146. [146] Szabo BM, Van Veldhuisen DJ, Brouwer J, De Graeff PA, Crijns HJGM. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997; 79: 978-79.
147. [147] Ponikowski P, Anker SD, Chua PT et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79.
148. [148] Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol 1997; 30: 1009-14.
149. [149] Ho KKL, Moody GB, Peng C et al. Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 1997; 96: 842-8.
150. [150] Mortara A, Sleight P, Pinna GD et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation 1997; 96: 246-52.
151. [151] Mortara A, La Rovere MT, Pinna GD et al. Arterial baroreflex modulation of heart rate in chronic heart failure. Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-8.
152. [152] Yi G, Goldman JH, Keeling PJ, Reardon M, McKenna WJ, Malik M. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 1997; 77: 108-14.
153. [153] Mortara A, Tavazzi L. Prognostic implications of autonomic nervous system analysis in chronic heart failure: role of heart rate variability and baroreflex sensitivity. Arch Geront Geriatrics 1996; 23: 265-75.
154. [154] Osterziel KJ, Hanlein D, Willenbrock R, Eichhorn C, Luft E, Dietz R. Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 1995; 73: 517-22.
155. [155] Menertz T, Treese N, Kasper W et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol 1985; 56: 337-41.
156. [156] Milner PG, DiMarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 1988; 11: 562-8.
157. [157] Stevenson WG, Stevenson LW, Weiss J, Tillisch JH. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J 1988; 116: 1447-54.
158. [158] Lindsay BD, Osborn JL, Schechtman KB et al. Prospective detection of vulnerability to sustained ventricular tachycardia in patients awaiting cardiac transplantation. Am J Cardiol 1992; 69: 619-24.
159. [159] Lee TH, Hamilton MA, Stevenson LW et al. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993; 72: 672-6.
160. [160] Wong M, Johnson G, Shabetai R et al. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: Veterans Affairs Cooperative Studies V-HeFT I and II. Circulation 1993; 87: V165-70.
161. [161] Madsen BK, Videbaek R, Stokholm H et al. Prognostic value of echocardiography in 190 patients with chronic congestive heart failure. Cardiology 1996; 87: 250-6.
162. [162] Kober L, Torp Pedersen C, Carlsen JE et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-6.
163. [163] Kober L, Torp Pedersen C, Carlsen J, Videbaek R, Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). Eur Heart J 1994; 15: 1616-20.
164. [164] Juilliere Y, Barbier G, Feldman A, Grentzinger N, Danchin N, Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 1997; 18: 276-80.
165. [165] Traversi E, Pozzoli M, Cioffi G et al. Mitral flow velocity changes after 6 months of optimised therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J 1996; 132: 809-19.
166. [166] Abramson SV, Burke JF, Kelly JJ. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Int Med 1992; 116: 888-95.
167. [167] Morley D, Brozena SC. Assessing risk by haemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol 1994; 73: 379-83.
168. [168] Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: Relation to symptoms and prognosis. Circulation 1994; 90: 2772-9.
169. [169] Werner GS, Schaefer C, Dirks et al. Prognostic value of doppler echocardiography assessment of left ventricular filling in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73: 792-8.
170. [170] Xie G, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 1994; 24: 132-9.
171. [171] Cleland JGF. Anticoagulant and antiplatelet therapy in heart failure. Curr Opinion Cardiol 1997; 12: 276-87.
172. [172] Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: Decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991; 122: 763.
173. [173] Marmor A, Schneeweiss A. Prognostic value of non-invasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 1997; 29: 422-8.
174. [174] Williams MJ, Odabashian J, Lauer MS et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 132-9.
175. [175] Nagaoka H, Isobe N, Kubota S et al. Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure. Chest 1997; 111: 344-50.
176. [176] di Salvo TG, Athier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995; 25: 1143-53.
177. [177] Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischaemic cardiomyopathy. Am J Cardiol 1995; 75: 759-62.
178. [178] Lee KS, Marwick TH, Cook SA et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Circulation 1994; 90: 2687-94.
179. [179] Ragosta M, Beller GA, Watson DD et al. Quantitative planar rest-distribution TI Imaging of myocardial viability and prediction in improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630-41.
180. [180] Gardin JM, Arnold A, Kitzman D et al. Congestive heart failure with preserved systolic function in a large community-dwelling elderly cohort: The cardiovascular health study. J Am Coll Cardiol 1995; 25: 423A..
181. [181] Cleland JGF. Screening for left ventricular dysfunction and heart failure: should it be done and if so how? Dis Management Health Outcomes 1997; 1: 169-84.
182. [182] Setaro JF, Soufer R, Remetz MS, Perlmutter RA, Zaret BL. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992; 69: 1212-16.
183. [183] Neubauer S, Horn M, Cramer M et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-6.
184. [184] Mancini DM, Eisen H, Kussmaul W et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
185. 2 determination in chronic heart failure: is it still of value? Eur Heart J 1994; 15: 495-502.
186. [186] Chomsky DB, Lang CC, Rayos GH et al. Haemodynamic exercise testing: a valuable tool in the selection of cardiac transplant candidates (Abstr). Circulation 1996; 94: I-290.
187. [187] Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55: 1037-42.
188. [188] Kao W, Winkel EM, Johnson MR, Piccione W, Lichtenberg R, Costanzo MR. Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance. Am J Cardiol 1997; 79: 1124-7.
189. [189] Kleber FX, Vietz G, Bauer U et al. Impairment of ventilatory efficiency predicts prognosis in patients with chronic heart failure (Abstr). Circulation 1996; 94: I-374.
190. [190] Bittner V, Weiner DH, Yusuf S et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. J Am Med Assoc 1993; 270: 1702-7.
191. 2 is superior to six minute walk for the prediction of survival in patients with heart failure. J Am Coll Cardiol 1996; 27: 367A.
192. [192] Chua TP, Ponikowski P, Harrington D et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29: 1585-90.
193. [193] MacGowan GA, Janosko K, Cecchetti A, Murali S. Exercise-related ventilatory abnormalities and survival in congestive heart failure. Am J Cardiol 1997; 79: 1264-6.
194. [194] Griffin BP, Shah PK, Ferguson J, Rubin SA. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991; 67: 848-53.
195. [195] Haywood GA, Rickenbacher PR, Trindale PT et al. Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. Heart 1996; 75: 455-62.
196. [196] Stevenson LW, Tillisch JH, Hamilton M et al. Importance of haemodynamic response to therapy in predicting survival with ejection fraction ≤20% secondary to ischemic or non-ischemic cardiomyopathy. Am J Cardiol 1990; 66: 1348-54.
197. [197] Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992; 19: 48-54.
198. [198] Roul G, Moulichon ME, Bareiss P et al. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 1995; 16: 1387-98.
199. [199] Mancini D, Katz, Donchez L, Aaronson K et al. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure. Circulation 1996; 94: 2492-6.
200. [200] Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-95.
201. [201] Passamani E, Davis KB, Gillespie MJ, Killip T and the CASS principal investigators and their associates. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985; 312: 1665-71.
202. [202] Christakis GT, Weisel RD, Fremes SE et al. Coronary artery bypass grafting in patients with poor venticular function. J Thorac Cardiovasc Surg 1992; 103: 1083-92.
203. [203] Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebisuzaki E. Results of revascularisation in patients with severe left ventricular dysfunction. Circulation 1995; 92 (Suppl II): II-73-II-79.
204. [204] Milano CA, White WD, Smith LR et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thoracic Surg 1993; 56: 487-93.
205. [205] Grogan M, Redfield MM, Bailey KR et al. Long-term outcome of patients with biopsy-proved myocarditis: Comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995; 26: 80-4.
206. [206] Pelliccia F, D'Amati G, Cianfrocca C et al. Histomorphometric features predict 1 year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation. Am Heart J 1994; 128: 316-25.
207. [207] Hammond EH, Menlove RL, Anderson JL. Predictive value of immunoflorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J 1987; 114: 1055-64.
208. [208] Why JF, Meany BT, Richardson PJ et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582-9.
209. [209] Clark AL, Coats AJS. Assessment of chronic heart failure. Br J Cardiology 1995; 2: 227-31.
210. [210] Anker SD, Coats AJS. Metabolic, functional, and haemodynamic staging for CHF. The Lancet 1996; 348: 1530-1.
211. [211] Adams KF, Califf RA, Harrell FEJ et al., for the FIRST investigators. Simple clinical characteristics not hemodynamics predict survival in advanced heart failure (Abstr). Heart Failure '97 1997; Cologne 24-27: 57.